Coco B - Search Results

1

HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis B.

Vecchi A, Rossi M, Tiezzi C, Fisicaro P, Doselli S, Gabor EA, Penna A, Montali I, Ceccatelli Berti C, Reverberi V, Montali A, Fletcher SP, Degasperi E, Sambarino D, Laccabue D, Facchetti F, Schivazappa S, Loggi E, Coco B, Cavallone D, Rosselli Del Turco E, Massari M, Pedrazzi G, Missale G, Verucchi G, Andreone P, Brunetto MR, Lampertico P, Ferrari C, Boni C. Vecchi A, et al. Among authors: coco b. Gut. 2024 Sep 9;73(10):1737-1748. doi: 10.1136/gutjnl-2024-332290. Gut. 2024. PMID: 39033025 Free PMC article. Clinical Trial.

2

Treatment of patients with chronic hepatitis C and cirrhosis.

Bonino F, Oliveri F, Colombatto P, Coco B, Mura D, Realdi G, Brunetto MR. Bonino F, et al. Among authors: coco b. J Hepatol. 1999;31 Suppl 1:197-200. doi: 10.1016/s0168-8278(99)80401-2. J Hepatol. 1999. PMID: 10622587 Review.

3

Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study.

Brunetto MR, Oliveri F, Coco B, Leandro G, Colombatto P, Gorin JM, Bonino F. Brunetto MR, et al. Among authors: coco b. J Hepatol. 2002 Feb;36(2):263-70. doi: 10.1016/s0168-8278(01)00266-5. J Hepatol. 2002. PMID: 11830339 Clinical Trial.

4

Hepatitis C virus infection: early diagnosis and identification of response to antiviral therapy.

Bonino F, Colombatto P, Civitano L, Coco B, Oliveri F, Brunetto MR. Bonino F, et al. Among authors: coco b. Expert Rev Mol Diagn. 2001 Sep;1(3):310-4. doi: 10.1586/14737159.1.3.310. Expert Rev Mol Diagn. 2001. PMID: 11901836 Review.

5

Treatment of HBeAg-negative chronic hepatitis B with interferon or pegylated interferon.

Brunetto MR, Oliveri F, Colombatto P, Coco B, Ciccorossi P, Bonino F. Brunetto MR, et al. Among authors: coco b. J Hepatol. 2003;39 Suppl 1:S164-7. doi: 10.1016/s0168-8278(03)00329-5. J Hepatol. 2003. PMID: 14708697 Review. No abstract available.

6

Sustained response to interferon-ribavirin combination therapy predicted by a model of hepatitis C virus dynamics using both HCV RNA and alanine aminotransferase.

Colombatto P, Civitano L, Oliveri F, Coco B, Ciccorossi P, Flichman D, Campa M, Bonino F, Brunetto MR. Colombatto P, et al. Among authors: coco b. Antivir Ther. 2003 Dec;8(6):519-30. Antivir Ther. 2003. PMID: 14760885

7

Early and accurate prediction of Peg-IFNs/ribavirin therapy outcome in the individual patient with chronic hepatitis C by modeling the dynamics of the infected cells.

Colombatto P, Ciccorossi P, Maina AM, Civitano L, Oliveri F, Coco B, Romagnoli V, Bonino F, Brunetto MR. Colombatto P, et al. Among authors: coco b. Clin Pharmacol Ther. 2008 Aug;84(2):212-5. doi: 10.1038/clpt.2008.21. Epub 2008 Mar 19. Clin Pharmacol Ther. 2008. PMID: 18388885

8

Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.

Brunetto MR, Oliveri F, Colombatto P, Moriconi F, Ciccorossi P, Coco B, Romagnoli V, Cherubini B, Moscato G, Maina AM, Cavallone D, Bonino F. Brunetto MR, et al. Among authors: coco b. Gastroenterology. 2010 Aug;139(2):483-90. doi: 10.1053/j.gastro.2010.04.052. Epub 2010 May 5. Gastroenterology. 2010. PMID: 20451520

9

Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B.

Lampertico P, Viganò M, Di Costanzo GG, Sagnelli E, Fasano M, Di Marco V, Boninsegna S, Farci P, Fargion S, Giuberti T, Iannacone C, Regep L, Massetto B, Facchetti F, Colombo M; PegBeLiver Study Group. Lampertico P, et al. Gut. 2013 Feb;62(2):290-8. doi: 10.1136/gutjnl-2011-301430. Epub 2012 Aug 2. Gut. 2013. PMID: 22859496 Clinical Trial.

10

Individualized treatment of HBeAg-negative chronic hepatitis B using pegylated interferon-α2a as first-line and week-12 HBV DNA/HBsAg stopping rule: a cost-effectiveness analysis.

Iannazzo S, Coco B, Brunetto MR, Rossetti F, Caputo A, Latour A, Espinos B, Bonino F. Iannazzo S, et al. Among authors: coco b. Antivir Ther. 2013;18(4):623-33. doi: 10.3851/IMP2555. Epub 2013 Mar 13. Antivir Ther. 2013. PMID: 23486701

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters